Market Overview:
The global mouth cancer treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of mouth cancer, increasing awareness about mouth cancer and its treatment options, and technological advancements in the field of radiotherapy and chemotherapy. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. The global mouth cancer treatment market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into radiotherapy, chemotherapy, and others (including surgery and laser therapy). Radiotherapy is further sub-segmented into external beam radiation therapy (EBRT) and brachytherapy. Chemotherapy is further sub-segmented into systemic chemotherapy and locoregional chemotherapy. On the basis of application, it can be classified into hospitals, diagnostic centers,, research centers,,and others (including private clinics). Among these regions,.However,.
Product Definition:
Mouth cancer treatment is the use of various methods to treat mouth cancer. Mouth cancer is a type of cancer that starts in the lips, tongue, gums, or other parts of the mouth. It can spread to other parts of the body. Treatment for mouth cancer may include surgery, radiation therapy, and chemotherapy.
Radiotherapy:
Radiotherapy is a form of cancer treatment in which the body is exposed to high doses of ionizing radiation. The most common types of cancers treated with radiotherapy include lung, breast, colorectal and stomach, head & neck cancer.
According to the American Cancer Society’s (ACS) research data published in NCBI it was stated that around 1 million patients are diagnosed with mouth or throat cancer every year globally.
Chemotherapy:
Chemotherapy is the use of drugs or chemical agents to treat cancer. Chemotherapy may be used in combination with radiation therapy, surgery, or a combination of both.
Application Insights:
Based on application, the market is segmented into hospitals, diagnostic centers, research centers and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and highly skilled medical staff at major locations across the globe.
The presence of various government initiatives such as National Cancer Center Japan (NCCJ) that aims to improve access to cancer care for Japanese population is expected to drive revenue from Japan over next few years. In addition, favorable reimbursement policies coupled with increasing awareness about early diagnosis are anticipated to further propel growth during the forecast period.
Diagnostic Centers are estimated to register significant growth over the forecast period due largely on increase in prevalence of mouth cancer cases globally along with rising demand for its treatment across North America and Europe regions.
Regional Analysis:
North America dominated the global mouth cancer treatment market in 2017. This can be attributed to the availability of technologically advanced devices, high adoption of oncological treatments, and increased funding for research activities. In addition, presence of key players in this region is expected to boost growth during the forecast period. For instance, as per Stryker Corporation; “In 2016 alone Stryker received over 70 U.
Growth Factors:
- Increasing incidence of mouth cancer
- Rising awareness about mouth cancer and its treatment options
- Growing demand for minimally invasive procedures for mouth cancer treatment
- Technological advancements in the field of oral oncology
- increasing number of Mouth Cancer Treatment clinics
Scope Of The Report
Report Attributes
Report Details
Report Title
Mouth Cancer Treatment Market Research Report
By Type
Radiotherapy, Chemotherapy, Others
By Application
Hospitals, Diagnostic Centers, Research Centers, Others
By Companies
Bristol-Myers Squibb, Qilu Pharmaceutical, Teva Pharmaceutical Industries, Eli Lilly And Company, Roche, Merck, Novartis, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Mouth Cancer Treatment Market Report Segments:
The global Mouth Cancer Treatment market is segmented on the basis of:
Types
Radiotherapy, Chemotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Research Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol-Myers Squibb
- Qilu Pharmaceutical
- Teva Pharmaceutical Industries
- Eli Lilly And Company
- Roche
- Merck
- Novartis
- Pfizer
Highlights of The Mouth Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiotherapy
- Chemotherapy
- Others
- By Application:
- Hospitals
- Diagnostic Centers
- Research Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mouth Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one definitive answer to this question as the best treatment for mouth cancer will vary depending on the type of mouth cancer, its location, and the individual’s health history. However, some common treatments for mouth cancer include surgery to remove the tumor (if it is localized), chemotherapy or radiation therapy to kill any remaining tumors, and/or a combination of these treatments.
Some of the major players in the mouth cancer treatment market are Bristol-Myers Squibb, Qilu Pharmaceutical, Teva Pharmaceutical Industries, Eli Lilly And Company, Roche, Merck, Novartis, Pfizer.
The mouth cancer treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mouth Cancer Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mouth Cancer Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mouth Cancer Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mouth Cancer Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mouth Cancer Treatment Market Size & Forecast, 2020-2028
4.5.1 Mouth Cancer Treatment Market Size and Y-o-Y Growth
4.5.2 Mouth Cancer Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Radiotherapy
5.2.2 Chemotherapy
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Research Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mouth Cancer Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mouth Cancer Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Radiotherapy
9.6.2 Chemotherapy
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Research Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Radiotherapy
10.6.2 Chemotherapy
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Research Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Radiotherapy
11.6.2 Chemotherapy
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Research Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Radiotherapy
12.6.2 Chemotherapy
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Research Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Radiotherapy
13.6.2 Chemotherapy
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Research Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mouth Cancer Treatment Market: Competitive Dashboard
14.2 Global Mouth Cancer Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bristol-Myers Squibb
14.3.2 Qilu Pharmaceutical
14.3.3 Teva Pharmaceutical Industries
14.3.4 Eli Lilly And Company
14.3.5 Roche
14.3.6 Merck
14.3.7 Novartis
14.3.8 Pfizer
